Jorrit De Waele
- Immunology top 5%
- Immune Cell Function and Interaction 9
- Immunotherapy and Immune Responses 6
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 5
- Pancreatic and Hepatic Oncology Research 3
- Cancer Research top 10%
-
- Occupational and environmental lung diseases 5
- Pleural and Pulmonary Diseases 4
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Evelien SmitsFilip LardonPatrick PauwelsJulie JacobsJonas R.M. Van AudenaerdeAn WoutersMarc PeetersChristophe Deben
- Cited by
- ImmunologyOncologyCancer Research
In The Last Decade
Jorrit De Waele
33 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 525
- Oncology 594
- Cancer Research 166
- Pulmonary and Respiratory Medicine 267
- Radiology, Nuclear Medicine and Imaging 168
Countries citing papers authored by Jorrit De Waele
This map shows the geographic impact of Jorrit De Waele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorrit De Waele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorrit De Waele more than expected).
Fields of papers citing papers by Jorrit De Waele
This network shows the impact of papers produced by Jorrit De Waele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorrit De Waele. The network helps show where Jorrit De Waele may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jorrit De Waele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 109 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 39 | |
| 12 | 2021 | 85 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 75 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 28 | |
| 17 | The potential and controversy of targeting STAT family members in cancerbreakdown → | 2019 | 273 |
| 18 | 2018 | 46 | |
| 19 | 2014 | 75 | |
| 20 | 2014 | 140 |
About Jorrit De Waele
Jorrit De Waele is a scholar working on Immunology, Oncology and Biotechnology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), Occupational and environmental lung diseases (5 papers), Pleural and Pulmonary Diseases (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Immunology (525 citations), Oncology (594 citations) and Cancer Research (166 citations). Jorrit De Waele has collaborated with scholars based in Belgium, Australia and Uganda. Frequent co-authors include Evelien Smits, Filip Lardon, Patrick Pauwels, Julie Jacobs, Jonas R.M. Van Audenaerde, An Wouters, Marc Peeters, Christophe Deben, Eva Lion and Elly Marcq. Their work appears in journals such as Cancers, Cells, OncoImmunology, Frontiers in Immunology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.